SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 |
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 1)*
|
IMMUCELL CORP /DE/ (Name of Issuer) |
Common Stock (Title of Class of Securities) |
452525306 (CUSIP Number) |
SRK CAPITAL, LLC 206 South Avenue, Ste 8 Media, PA, 19063 (610) 424-1017 SEAN KIRKWOOD 206 South Avenue, Ste 8 Media, PA, 19063 (610) 424-1017 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) |
09/17/2024 (Date of Event Which Requires Filing of This Statement) |
SCHEDULE 13D
|
CUSIP No. | 452525306 |
1 |
Name of reporting person
SRK FUND I, LP | ||||||||
2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b) | ||||||||
3 | SEC use only | ||||||||
4 |
Source of funds (See Instructions)
WC | ||||||||
5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
6 | Citizenship or place of organization
DELAWARE
| ||||||||
Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
11 | Aggregate amount beneficially owned by each reporting person
502,258.00 | ||||||||
12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
13 | Percent of class represented by amount in Row (11)
6.4 % | ||||||||
14 | Type of Reporting Person (See Instructions)
PN |
SCHEDULE 13D
|
CUSIP No. | 452525306 |
1 |
Name of reporting person
SRK Capital, LLC | ||||||||
2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b) | ||||||||
3 | SEC use only | ||||||||
4 |
Source of funds (See Instructions)
OO | ||||||||
5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
6 | Citizenship or place of organization
PENNSYLVANIA
| ||||||||
Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
11 | Aggregate amount beneficially owned by each reporting person
502,258.00 | ||||||||
12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
13 | Percent of class represented by amount in Row (11)
6.4 % | ||||||||
14 | Type of Reporting Person (See Instructions)
OO |
SCHEDULE 13D
|
CUSIP No. | 452525306 |
1 |
Name of reporting person
Sean Kirkwood | ||||||||
2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b) | ||||||||
3 | SEC use only | ||||||||
4 |
Source of funds (See Instructions)
OO | ||||||||
5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
6 | Citizenship or place of organization
UNITED STATES
| ||||||||
Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
11 | Aggregate amount beneficially owned by each reporting person
502,258.00 | ||||||||
12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
13 | Percent of class represented by amount in Row (11)
6.4 % | ||||||||
14 | Type of Reporting Person (See Instructions)
OO |
SCHEDULE 13D
|
Item 1. | Security and Issuer |
(a) | Title of Class of Securities:
Common Stock |
(b) | Name of Issuer:
IMMUCELL CORP /DE/ |
(c) | Address of Issuer's Principal Executive Offices:
56 EVERGREEN DR, 56 EVERGREEN DR, PORTLAND,
MAINE
, 04103. |
Item 3. | Source and Amount of Funds or Other Consideration |
The shares purchased by SRK Fund were purchased with working capital (which may, at any given time, include margin loans made by brokerage firms in the ordinary course of business) in open market purchases, except as otherwise noted. The aggregate purchase price of the 502,258 Shares beneficially owned by SRK Fund is approximately $2,430,957. | |
Item 5. | Interest in Securities of the Issuer |
(a) | As of the date hereof, SRK Fund beneficially owned 502,258 Shares. Representing approximately 6.4% of the outstanding shares.
SRK Capital, as the general partner of SRK Fund, may be deemed the beneficial owner of the 502,258 Shares owned by SRK Fund. Representing approximately 6.4% of the outstanding shares.
Mr. Kirkwood, as the sole owner, member, and manager of SRK Capital, may be deemed the beneficial owner of the 502,258 Shares owned by SRK Fund. Representing approximately 6.4% of the outstanding shares. |
(b) | SRK Fund:
1. Sole power to vote or direct vote: 0
2. Shared power to vote or direct vote: 502,258
3. Sole power to dispose or direct the disposition: 0
4. Shared power to dispose or direct the disposition: 502,258
SRK Capital:
1. Sole power to vote or direct vote: 0
2. Shared power to vote or direct vote: 502,258
3. Sole power to dispose or direct the disposition: 0
4. Shared power to dispose or direct the disposition: 502,258
Mr. Kirkwood:
1. Sole power to vote or direct vote: 0
2. Shared power to vote or direct vote: 502,258
3. Sole power to dispose or direct the disposition: 0
4. Shared power to dispose or direct the disposition: 502,258 |
(c) | This Schedule sets forth information with respect to each purchase and sale of shares of Common Stock which were effectuated by the Reporting Person within the past sixty (60) days. All transactions were effectuated in the open market through a broker. Where the price reported in the column titled "Price Per Share ($)" is a weighted average price. The Reporting Persons will undertake to provide to the staff of the SEC, upon request, full information regarding the number of shares of Common Stock sold or purchased at each separate price.
Trade Date Shares Purchased Price Per Share ($)
7/19/2024 3,900 4.19
7/25/2024 7,200 4.08
8/02/2024 22,900 3.99
8/05/2024 5,622 3.72
8/06/2024 2,446 3.89
8/08/2024 5,701 3.70
8/13/2024 100 3.82
8/22/2024 4,900 3.55
8/27/2024 6,810 3.85
8/29/2024 16,601 3.80
9/10/2024 1,000 3.85
9/17/2024 12,000 3.48 |
(d) | To the knowledge of any of the Reporting Persons, no other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Shares reported in this Item 5. |
(e) | Not applicable. |
SIGNATURE | |
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
|
|
|
|
|
|